NCT06888843 2025-03-27
AHTCRR-1
Nizhny Novgorod Regional Clinical Oncology Center
Phase 2 Recruiting
Clinical Trials
26 trialsNCT06746545 2024-12-24
A Prospective, Open-label, Single-arm Phase II Clinical Study of Fruquintinib Combined With S-1 for the Treatment of Metastatic Colorectal Cancer.
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06321081 2024-03-20
ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC
Beijing Hospital
Phase 2 Recruiting
NCT06293014 2024-03-05
TAS-102 Combined With Bevacizumab for Second-line Maintenance Treatment of Advanced Colorectal Cancer
Henan Cancer Hospital
Phase 2 Recruiting
NCT05839470 2023-11-15
Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT05913570 2023-06-22
MSI-H/dMMR
Henan Cancer Hospital
Phase 2 Unknown
NCT05799443 2023-04-05
Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT05314101 2022-08-23
TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT03940131 2022-04-06
REPAN
King Abdullah Medical City
Phase 2 Unknown
NCT05266820 2022-03-18
Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT00640081 2021-09-22
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer
Medical Research Council
Phase 2 Completed
NCT04775862 2021-03-01
A Prospective Study Utilizing Circulating Cell Free DNA (cfDNA) Use in the Detection of RAS Mutations in Patients With Advanced Colorectal Cancer.
National Guard Health Affairs
Phase 2 Unknown
NCT04593446 2020-10-20
Difference of Surgical Site Infection Between Using Sodium Picosulfate Solution(PicosolutionⓇ) and Oral Sulfate Tablet(ORA·FANGⓇ) in Colorectal Cancer Surgery
National Cancer Center, Korea
Phase 2 Unknown
NCT04475159 2020-07-17
Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial
Sheba Medical Center
Phase 2 Unknown
NCT03397199 2020-04-15
Study of Apatinib Plus S-1 as the Therapy of Advanced Colorectal Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT03919461 2019-04-18
COMPIT-2
Assaf-Harofeh Medical Center
Phase 2 Recruiting
NCT03222089 2018-03-27
Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC
Fujian Cancer Hospital
Phase 2 Withdrawn
NCT03093129 2018-01-09
NeoART-V
The 108 Military Central Hospital
Phase 2 Unknown
NCT02490709 2015-07-07
Local Excision of Clinical T3 Rectal Adenocarcinoma Showing Major Response(ycT0-1) After Neoadjuvant Chemoradiotherapy
National Cancer Center, Korea
Phase 2 Unknown
NCT00557102 2012-12-11
ERBIFORT
National Cancer Institute, France
Phase 2 Completed
NCT01269060 2012-08-06
Efficacy of Single Incision (Embryonic NOTES) Laparoscopic Colorectal Surgery
National Cancer Center, Korea
Phase 2 Completed
NCT00784667 2010-11-30
Dux
Austin Health
Phase 2 Unknown
NCT01249521 2010-11-30
Vengeance
Austin Health
Phase 2 Unknown
NCT00506168 2007-07-25
Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer
National Cancer Center, Korea
Phase 2 Terminated
NCT00506571 2007-07-25
TIROX2
National Cancer Center, Korea
Phase 2 Unknown
NCT00468416 2007-05-04
Evaluation of NiTi Shape Memory End-to-End Compression Anastomosis Ring (CAR) for Compression Anastomosis in Anterior Resection
Tel-Aviv Sourasky Medical Center
Phase 2 Unknown